Predictors of Having a Resistance Test following Confirmed Virological Failure of Combination Antiretroviral Therapy: Data from Eurosida | Zendy

Zoë Fox | Zendy; Alessandro CozziLepri | Zendy; Antonella d’Arminio Monforte | Zendy; Anders Karlsson | Zendy; Andrew Phillips | Zendy; Gitte Kronborg | Zendy; Jesper Kjær | Zendy; Bonaventura Clotet | Zendy; Jens Lundgren | Zendy

Open Access

Predictors of Having a Resistance Test following Confirmed Virological Failure of Combination Antiretroviral Therapy: Data from Eurosida

Author(s) -

Zoë Fox,

Alessandro CozziLepri,

Antonella d’Arminio Monforte,

Anders Karlsson,

Andrew Phillips,

Gitte Kronborg,

Jesper Kjær,

Bonaventura Clotet,

Jens Lundgren

Publication year - 2010

Publication title -

antiviral therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.747

H-Index - 87

eISSN - 2040-2058

pISSN - 1359-6535

DOI - 10.3851/imp1801

Subject(s) - antiretroviral therapy , medicine , didanosine , viral load , human immunodeficiency virus (hiv) , virology

Guidelines suggest that patients on continuous antiretroviral therapy for >4 months with current viral load (VL)>1,000 copies/ml should be tested for resistance. There are limited data showing the frequency of resistance testing in routine clinical practice following these recommendations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research